↓ Skip to main content

Dove Medical Press

US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
7 Mendeley
Title
US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma
Published in
ClinicoEconomics and Outcomes Research: CEOR, June 2021
DOI 10.2147/ceor.s305830
Pubmed ID
Authors

Mike Dolph, Gabriel Tremblay, Hoyee Leong

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 14%
Other 1 14%
Student > Doctoral Student 1 14%
Unknown 4 57%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 2 29%
Business, Management and Accounting 1 14%
Unknown 4 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2022.
All research outputs
#3,430,877
of 25,462,162 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#74
of 525 outputs
Outputs of similar age
#83,664
of 460,212 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#6
of 20 outputs
Altmetric has tracked 25,462,162 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 525 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,212 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.